Advanced Technology Pharmaceuticals Corporation – Trademark Portfolio

Entity Type: 03

Advanced Technology Pharmaceuticals Corporation holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. Currently, 1 trademark is registered. Notable registered marks include TIGER PAW. The owner is based in DACULA, GA.

1870 FENCE ROAD

DACULA, GA 30019

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Advanced Technology Pharmaceuticals Corporation's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Advanced Technology Pharmaceuticals Corporation have?

Advanced Technology Pharmaceuticals Corporation has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 1 cancelled.

What trademark classes does Advanced Technology Pharmaceuticals Corporation file in?

Advanced Technology Pharmaceuticals Corporation files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Advanced Technology Pharmaceuticals Corporation's most well-known trademarks?

Advanced Technology Pharmaceuticals Corporation's registered trademark portfolio includes well-known marks such as TIGER PAW. These are among 1 currently registered trademark in the portfolio.

What is Advanced Technology Pharmaceuticals Corporation's trademark registration success rate?

Advanced Technology Pharmaceuticals Corporation has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.